| 查看: 2738 | 回复: 23 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章，编辑回复如下： Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher"  agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" in the following journal: **********************("the Journal" 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
回复此楼» 猜你喜欢
梦想
已经有7人回复
-
学科评审组评审是指会评吗？
已经有4人回复
-
面上合作单位盖章
已经有8人回复
-
面上函评意见出来了，像什么等级？
已经有15人回复
-
为什么资助数各大高校都创新高，自己申请怎么就这么难
已经有14人回复
-
小白求助 投论文要求的highlights应该如何写
已经有4人回复
-
麻烦专家们看看评委们的意见（F口面上）
已经有12人回复
-
怎么看青基中了没有啊
已经有6人回复
-
国社科又开始会评了，不知道这次命运如何
已经有11人回复
-
有多少人是今天查系统知道结果的？
已经有19人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 请大家帮我分析这个产物能不能过柱纯化呢？
已经有27人回复
- 麻烦大家帮我分析分析
已经有4人回复
- 各位大牛，帮我分析下出国公派读博，是不是离我越来越远了？
已经有27人回复
- 大家帮我分析下导师的答复，是不是没有什么希望，谢谢大家了！！！
已经有5人回复
- 这个导师是什么意思呢，大家帮我分析一下吧。
已经有46人回复
- 哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
- 北京和深圳，哪个好呢？请大家帮我分析下
已经有28人回复
- 大家帮我分析分析
已经有4人回复
- 【求助】大家来帮我分析下是不是要这么久
已经有14人回复
- 大家帮我分析一下有没有这种可能呢？谢谢
已经有13人回复
» 抢金币啦！回帖就可以得到:
-
【征稿中！】2026年机械、制造技术与材料国际会议 (MEMTM 2026)
+1/920
-
【IEEE列表会议征稿 】2026年第六届控制理论与应用国际会议（ICoCTA 2026）
+5/885
-
云南大学丁军桥团队2027年博士招生
+1/811
-
基金高中！
+1/596
-
优质男征女友
+1/470
-
昆明理工大学智能车辆技术团队招聘博士后
+3/225
-
【以色列理工学院全额奖学金硕博士招生】王燕课题组 · 柔性生物界面实验室
+2/122
-
天平合规性问题
+1/93
-
【半导体薄膜代工】ALD/CVD/磁控溅射/热蒸发全工艺
+1/88
-
大湾区大学刘天辉课题组招收2027级博士生（与中山大学物理学院联合培养）
+1/46
-
大湾区大学刘天辉课题组招收2027级博士生（与中山大学物理学院联合培养）
+1/45
-
山东大学-山东字节信息智能技术实验室2026年招聘博士后
+2/24
-
评职称需要，卖发明专利了:D有技术储备需求的设备厂商可联系
+1/19
-
浙江大学物理高等研究院袁怀洋课题组诚聘博士和博士后
+1/17
-
中国药科大学陈达威课题组招收2027年博士研究生 （药理学）
+1/14
-
义翘神州推出全长p-Tau217蛋白，助力阿尔茨海默病下一代生物标志物检测开发
+1/7
-
义翘神州TR-FRET激酶检测试剂盒助力高通量药物筛选
+1/2
-
项目助理招聘启事
+1/2
-
义翘神州TR-FRET激酶检测试剂盒助力高通量药物筛选
+1/2
-
中国科学院广州生物医药与健康研究院课题组招收博士研究生1名（2027年9月入学）
+1/1
18楼2011-04-01 09:16:47
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
4楼2011-03-31 16:19:31
